Navigation Links
Donald W. Wyatt Detention Facility Scores 3-Year Accreditation and Among Highest Rated in the United States
Date:4/4/2008

"Nearly Perfect" Score by the American Correctional Association Auditors

Earns High Praise From Board Chair Romanowicz

CENTRAL FALLS, R.I., April 4, 2008 /PRNewswire/ -- After an exhaustive three-day audit and examination by the American Correctional Association Commission on Accreditation, the Central Falls Detention Facility Corporation is pleased to report that the Donald W. Wyatt Detention Facility has passed with a 99.7% rating. This gives the facility a three-year reaccreditation status for the fourth time in its 15-year history and marks its consistent accredited status since 1995 when the facility applied for its first rating.

A seasoned team of correctional practitioners led by Kaye Harris, RN/BS, a career Federal Bureau of Prisons employee, conducted the comprehensive and intensive three-day audit. Together, the team represented a combined experience of over 100 years in senior level correctional management.

Through accreditation, an agency is able to maintain a balance between protecting the public and providing an environment that safeguards the life, health and safety of staff and offenders. Standards set by the ACA reflect practical up-to-date policies and procedures, and function as a management tool for more than 1,500 correctional agencies in the United States.

The Wyatt Facility was tested against 384 applicable standards listed in the ACA's Adult Local Detention Facilities Manual, 4th Edition, on virtually all aspects of correctional operations, from security and physical plant to use of force; medical; programs; and food services. Of the 384 standards, 60 are mandatory life safety and must be passed. The one standard where the facility did not fully comply was minor, related to the number of showerheads in a newly constructed living POD. The Wyatt has addressed it, and is finishing this installation; and will appeal this specific finding before May 2008, when the formal commission award is present
'/>"/>

SOURCE Central Falls Detention Facility Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
2. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
3. University of Houstons Achenbaum wins GSAs 2007 Donald P. Kent Award
4. Arete Therapeutics Appoints Donald Santel to Board of Directors
5. Philadelphia Ronald McDonald House(R) at Front & Erie Celebrates Grand Opening
6. Statement by Oscar S. Wyatt, Jr.
7. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
8. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
9. Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find
10. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
11. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5